Last month, the Supreme Court of Canada (SCC) denied leave to appeal in the case Eli Lilly Canada Inc v Novopharm Ltd, passing on an opportunity to clarify the controversial “promise of the patent” utility requirement for Canadian pharmaceutical patents.

Posted in Canada, European Union, Infringement, IP, Jurisdiction, Patentability, Patents, Pharmaceutical Drugs, Regulatory Policy, Supreme Court of Canada, UK, UK, US, US-Canada Relations
Comments: 0

Gift cards are everywhere. They are in envelopes as gifts for your friends on their birthdays. They are in your own wallet for your favourite stores. Gift cards are also in the United States Court of Appeals.

Posted in Infringement, Patentability, Patents, Technology, US
Comments: 0

There have been many high profile court cases of patent infringement in the past year, culminating in a headline-topping $1 billion award for Apple against Samsung. Even with massive awards like this, at the end of the day, has the patent system produced a net benefit for Apple and the smartphone industry as a whole?

Posted in Infringement, IP, Patents, Smartphones
Comments: 0

An intermediate bulk container (IBC) was the subject of an ongoing patent suit between exclusive UK licensee of the patent, Schütz (U.K.) Limited (Schütz), and Werit UK Limited (Werit). IBC’s are bulk liquid shipping containers with wire frames surrounding a plastic container in order to improve structural stability. IBCs are designed this way in order to [...]

Posted in Infringement
Comments: 0